| Tag | Content |
|---|
EnhancerAtlas ID | HS012-00227 |
Organism | Homo sapiens |
Tissue/cell | Caco-2 |
Coordinate | chr1:39737520-39738410 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| GATA2 | MA0036.3 | chr1:39737851-39737862 | ACAGATAAGAA | - | 6.14 | | Gata1 | MA0035.3 | chr1:39737851-39737862 | ACAGATAAGAA | - | 6.62 | | NR2C2 | MA0504.1 | chr1:39738088-39738103 | GGAGGGCAAGGGTCA | + | 6.2 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_11519 | chr1:39737327-39739322 | CD20 | | SE_13363 | chr1:39737120-39738383 | CD34_Primary_RO01536 | | SE_18276 | chr1:39737303-39738655 | CD4p_CD25-_Il17-_PMAstim_Th |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I039271 | chr1 | 39737053 | 39739052 |
|
Enhancer Sequence | GGCAAGGGAA TGTTCTGCAT GAGTCTGTGA GGAGTCTTAA AGAAAAGATT GTTAGGAGAA 60
ACCTTTGGAC CATGATCTGT AGTGTGACCA TATTGGCAAC AGTATGATTC CTTTGCTGTT 120
CAGTATGATT CAAATTGGTG TGTGGCATTT TCTGGGTAGC CAACCTCTGC ATCTATTCCT 180
TCTACCTTTT CACTGCAGAC ACAGTCATAC TACTTATGTA TAGCCAAGGC TGAAAAACTA 240
AGTGACCGAG TCTCAGCTCA GACACCTGGC ATATTTCCAG GTTTTGTGTC CATCATGTGA 300
TACAGGGACC ACAGACTCAC CATCCTATAT GACAGATAAG AAGTAACTTA TCAAGATAAG 360
TGTGACATTC CTTCAGAATG AAAGTCCTTA AGGCCAAGAG GCTGCAACTC TCACTGGTCC 420
CTGAAGGAAC TGTCTTCAGG GAGCTGCTCC CCTCCCTAAC AGGCTGTTCA CAGGCTTGAG 480
GACAGTAGCA GCCAGAGAAA CAGAGAGGGC AACGCATACT GAAACCGATA GGCAGGGCAA 540
GAGCATCTCT GCTAAAGTGG GAAAGCTGGG AGGGCAAGGG TCAGAAGAGC AGCTGCTGCT 600
GTTCACACAC CAACTCCTGT CTAAACAGGA GACAGCTGGC AGTCCAATTG AGTTGTTTTT 660
TGCTTGCTTT TTTGGTGGTG GTTTTGTTTT TAATATGTCA GAGTAGTAAC TATCCTCAGA 720
AAATAATTTG AGTTCCAGCC AGACTGTCTC CTCTGTTGAT TAGTCCAGGG CTTGTTGATG 780
AGAGTGAGAC CAGGCTATGG ATAGACATAA ACTTCACCAT GGGTTTTGTT GCTTTTTAGG 840
ATGGAGAGAA ATGGGAACTG ATTGTGCTTC TTGCTAGTGT AGGGTTTAGA 890
|
